The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

305 indexed citations

Abstract

loading...

About

This paper, published in 2016, received 305 indexed citations. Written by Jennifer Hodge, Thomas T. Kawabata, Sriram Krishnaswami, James D. Clark, Jean‐Baptiste Telliez, Martin E. Dowty, Sujatha Menon, Manisha Lamba and Samuel H. Zwillich covering the research area of Oncology, Rheumatology and Pharmacology. It is primarily cited by scholars working on Rheumatology (153 citations), Immunology (94 citations) and Oncology (85 citations). Published in PubMed.

In The Last Decade

doi.org/w51627958 →

Countries where authors are citing The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

Specialization
Citations

This map shows the geographic impact of The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. more than expected).

Fields of papers citing The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w51627958.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026